Related Experiment Video
Updated: Jul 3, 2026

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in
A Lespagnol1, D Duflaut, C Beekman
1Laboratoire de Biotechnologie et Pharmacologie génétique Appliquée (LBPA), Ecole Normale Supérieure, Cachan, France.
Abstract:
TSAP6 (tumor suppressor-activated pathway 6), also known as Steap3, is a direct p53 transcriptional target gene. It regulates protein secretion, for example translationally controlled tumor protein (TCTP), which is implicated in tumor reversion. In keeping with the latter, we show herein that TSAP6 is a glycosylated protein present in the trans-Golgi network, endosomal-vesicular compartment and cytoplasmic membrane. To further investigate the physiological function of TSAP6, we have generated TSAP6-deficient mice. These mice exhibit microcytic anemia with abnormal reticulocyte maturation and deficient transferrin receptor downregulation, a process known to be dependent on exosomal secretion. Moreover, we provide direct evidence that exosome production is severely compromised in TSAP6-null cells. Finally, we show that the DNA damage-induced p53-dependent nonclassical exosomal secretory pathway is abrogated in TSAP6-null cells. Given the fact that exosomes are used as cell-free vaccines against cancer and that they could be involved in the biogenesis and spread of human immunodeficiency virus, it is important to understand their regulation. The results presented here provide the first genetic demonstration that exosome formation is a tightly controlled biological process dependent of TSAP6.
Insights
Tumor suppressor-activated pathway 6 (TSAP6) is crucial for exosome production. TSAP6 deficiency in mice leads to anemia and impaired exosome secretion, highlighting its role in cellular communication.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- TSAP6 (Steap3) is a p53 target gene regulating protein secretion, including TCTP, linked to tumor reversion.
- TSAP6 is a glycosylated protein localized in the trans-Golgi network, endosomal-vesicular compartment, and cytoplasmic membrane.
Purpose of the Study:
- To investigate the physiological function of TSAP6 in exosome biogenesis and secretion.
- To determine the role of TSAP6 in cellular processes affected by exosome regulation, such as anemia and transferrin receptor downregulation.
Main Methods:
- Generation and analysis of TSAP6-deficient mice.
- Biochemical and cellular analysis of TSAP6-null cells.
- Investigation of the DNA damage-induced p53-dependent exosomal secretory pathway.
Main Results:
- TSAP6-deficient mice exhibit microcytic anemia with abnormal reticulocyte maturation and impaired transferrin receptor downregulation.
- Exosome production is severely compromised in TSAP6-null cells.
- The DNA damage-induced p53-dependent nonclassical exosomal secretory pathway is abrogated in TSAP6-null cells.
Conclusions:
- TSAP6 is essential for exosome formation and secretion.
- TSAP6 plays a critical role in regulating exosome-dependent cellular processes, including transferrin receptor downregulation.
- This study provides the first genetic evidence that exosome formation is tightly controlled by TSAP6.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
The Extrinsic Apoptotic Pathway
